Australian CKD guidelines recommend the use of angiotensin-converting enzyme inhibitors (ACEis) or angiotensin-receptor blockers (ARBs) in the presence of albuminuria or hypertension (defined as a blood pressure above 130/80 mm Hg), and statins are recommended for everyone with CKD over the age of 50 years or for younger individuals with CKD in the presence of comorbidities [5]. Here, ACE is linked to chronic kidney disease.